Answers are grounded in this paper and cite their sources.
Liver cancer, which includes hepatocellular carcinoma and metastatic progression, still remains a major global health challenge due to late-stage diagnosis and limited therapeutic technologies. The proposed Layered Square Maze Pattern Refractive Index Biosensor (LSMPRIB) offers a promising route for early detection and discrimination of normal hepatocellular carcinoma (NHC) & cancerous hepatocellular carcinoma (CHC) and normal liver metastasis (NLM) & cancerous liver metastasis (CLM) by enabling label-free and real-time monitoring of liver tumour biomarkers. The proposed design integrates advanced photonic geometry to enhance sensitivity and specificity for liver cancer biomarkers. With the tuned structural dimension, the LSMPRIB sensor achieves an optimized sensitivity of 1055.55 nm/RIU, 1000.00 nm/RIU, and optimized detection limit of 0.000302 RIU, and 0.000615 RIU for detection of CHC, and CLM, respectively. The optimized quality factor of 1230.83, 1458.00, 1327.27, 1329.09, and optimized detection range of 1355.04 RIU, 1337.61 RIU, 1403.84 RIU, and 1405.76 RIU for detection of NHC, CHC, NLM, and CLM, respectively. Further, machine learning-driven regression has been studied for the predictive accuracy of the LSMPRIB response. This achieves the most favourable linear regression R 2 score of 0.998521, with an MSE (mean squared error) score of 5.291722 × 10 −7 . This LSMPRIB biosensor study highlights the potential of refractive index biosensors as reliable diagnostic tools for clinical translation in liver cancer management.
No takes yet. Share an insight, caveat, or question.
Alsharari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: